Antitubercular Drugs: Mechanisms, Modern TB Regimens and Safety

Medical education review; updated 10 November 2026. Regimens must be individualized and checked against local guidelines. Overview Tuberculosis (TB) treatment requires combinations of active drugs to cure disease and prevent acquired resistance. Regimen selection depends on drug-susceptibility testing, anatomic site, age, pregnancy, HIV status, prior treatment and local TB program guidance [1,2]. First-line pharmacology Isoniazid…

Read Full News

Tetracyclines and Chloramphenicol: Mechanisms, Clinical Uses and Safety

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Tetracyclines are protein-synthesis inhibitors used for selected respiratory, tick-borne, sexually transmitted and dermatologic infections. Chloramphenicol, a distinct 50S inhibitor, is now reserved for unusual situations because of serious hematologic toxicity [1–3]. Classification and mechanism…

Read Full News

Aminoglycoside Antibiotics: 30S Mechanism, PK/PD, Monitoring and Toxicity

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Aminoglycosides are rapidly bactericidal, concentration-dependent antibiotics chiefly used for susceptible aerobic Gram-negative bacterial infections and selected combination regimens. Their narrow therapeutic index makes susceptibility testing, renal assessment and drug-level monitoring central to safe use…

Read Full News

Macrolide Antibiotics: Ribosomal Action, Clinical Uses, Resistance and QT Safety

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Macrolides include erythromycin, clarithromycin and azithromycin. They inhibit bacterial protein synthesis and remain useful for certain atypical respiratory pathogens, pertussis and selected other infections; widespread resistance limits empiric use for some syndromes [1–3]. Classification…

Read Full News

Fluoroquinolones: DNA Gyrase Inhibition, Clinical Indications and Serious Warnings

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Fluoroquinolones are synthetic, concentration-dependent bactericidal antibiotics that inhibit bacterial type II topoisomerases. Their favorable oral absorption must be weighed against resistance and potentially severe adverse effects; they are not routine first-line agents for minor…

Read Full News

Sulfonamides and Cotrimoxazole: Folate Inhibition, Clinical Uses and Monitoring

Educational review updated 10 November 2026. Antimicrobial selection and dosing must reflect patient factors, susceptibility data and current local guidance. Overview Antibacterial sulfonamides were among the earliest effective systemic antibiotics. Cotrimoxazole combines sulfamethoxazole (SMX), a sulfonamide, with trimethoprim (TMP), a diaminopyrimidine, not a second sulfonamide. Their sequential blockade of folate synthesis provides activity against selected…

Read Full News

Beta-Lactam Antibiotics: Mechanisms, Classification, Resistance and Clinical Use

Reviewed 10 November 2026 for medical education. This material is not a prescribing protocol; apply local clinical guidance and individual assessment. Introduction and learning objectives Beta-lactams inhibit bacterial cell-wall synthesis and are foundational to treating susceptible bacterial infections. Choosing among them requires understanding penicillin-binding proteins (PBPs), beta-lactamases, time-dependent killing, site of infection, allergy history, local…

Read Full News

Bisphosphonates and PTH Analogues: Osteoporosis Pharmacology and Treatment Sequencing

Reviewed 10 November 2026 for medical education. This material is not a prescribing protocol; apply local clinical guidance and individual assessment. Overview Osteoporosis pharmacotherapy reduces fracture risk by decreasing bone resorption or stimulating formation. Treatment decisions combine prior fractures, bone mineral density (BMD), clinical risk, kidney function, adverse effects and individual preference [1–3]. Correct classification…

Read Full News

Tocolytic Drugs: Preterm Labour, Nifedipine, Atosiban and Safety

Reviewed 10 November 2026 for medical education. This material is not a prescribing protocol; apply local clinical guidance and individual assessment. Clinical objectives Tocolysis temporarily delays preterm birth in appropriately selected patients, chiefly to permit antenatal corticosteroids, magnesium sulfate for fetal neuroprotection where indicated, and transfer to higher-level neonatal care. It does not reliably prevent…

Read Full News

Uterotonics for Postpartum Haemorrhage: Oxytocin, Carbetocin and Prostaglandins

Reviewed 10 November 2026 for medical education. This material is not a prescribing protocol; apply local clinical guidance and individual assessment. Overview Uterotonics contract uterine smooth muscle, principally to prevent or manage postpartum haemorrhage (PPH) from uterine atony. Choice reflects evidence, availability, contraindications, cold-chain constraints and whether the aim is prevention or treatment [1–3]. Correct…

Read Full News